EELHOE Mole Reduce Essence
NDC 85064-002, SALICYLIC ACID, liquid, from Shantou Eelhoe Daily Chemical Technology Co., Ltd..
- Product NDC
- 85064-002
- Status
- Listed
- Labeler
- Shantou Eelhoe Daily Chemical Technology Co., Ltd.
- Dosage form
- LIQUID
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M006
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85064-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CAMELLIA SINENSIS LEAF.002 mg/10mg
- MELALEUCA ALTERNIFOLIA (TEA TREE) LEAF OIL.002 mg/10mg
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85064-002-01 | 85064000201 | 10 mg in 1 BOTTLE (85064-002-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 85064-002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85064-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85064-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.